Immuron Limited
ASX:IMC.AX
Overview | Financials
Company Name | Immuron Limited |
Symbol | IMC.AX |
Currency | AUD |
Price | 0.077 |
Market Cap | 17,644,165 |
Dividend Yield | 0% |
52-week-range | 0.065 - 0.17 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Steven George Lydeamore CPA, CPA, M.B.A., MBA |
Website | https://www.immuron.com.au |
An error occurred while fetching data.
About Immuron Limited
Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, Israel, Canada, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. It offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD